Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page has updated the study details for the IMPRINT-Lung study, including a new estimated last update date of February 2025 and a change in the principal investigator's contact information. Additionally, the previous estimated recruitment date has been removed.SummaryDifference3%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check46 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check68 days agoChange DetectedThe website has updated the intervention details and contact information for Principal Investigator Jianjun Zhang, moving from version v2.13.3 to v2.14.0.SummaryDifference0.7%
- Check96 days agoChange DetectedThe website has added several new dates, including 2024-12-12 and 2025-12-31, along with an update to Revision v2.13.3, while removing earlier dates and reverting to Revision v2.13.2.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.